Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410259 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2025-09-09 |
| 12233093 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Irving L. Weissman, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr | 2025-02-25 |
| 12195532 | High affinity SIRP-alpha reagents and methods of using | Aaron Michael Ring, Kenan Christopher Garcia, Aron Levin, Irving L. Weissman | 2025-01-14 |
| 12030944 | Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist | Peter Schnorr, Akanksha Chhabra, Judith A. Shizuru, Irving L. Weissman | 2024-07-09 |
| 11780931 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2023-10-10 |
| 11608377 | Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist | Peter Schnorr, Akanksha Chhabra, Judith A. Shizuru, Irving L. Weissman | 2023-03-21 |
| 11459388 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Aaron Michael Ring, Irving L. Weissman | 2022-10-04 |
| 11419897 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Irving L. Weissman, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr | 2022-08-23 |
| 11230607 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2022-01-25 |
| 11208481 | High affinity SIRP-alpha reagents and methods of using | Aaron Michael Ring, Kenan Christopher Garcia, Aron Levin, Irving L. Weissman | 2021-12-28 |
| 11154600 | Use of anti-CD47 agents to enhance immunization | Diane Tseng, Jens-Peter Volkmer, Stephen Willingham, Irving L. Weissman | 2021-10-26 |
| 11046763 | Targeted therapy for small cell lung cancer | Julien Sage, Irving L. Weissman | 2021-06-29 |
| 10894831 | Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist | Peter Schnorr, Akanksha Chhabra, Judith A. Shizuru, Irving L. Weissman | 2021-01-19 |
| 10889649 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Aaron Michael Ring, Irving L. Weissman | 2021-01-12 |
| 10781256 | Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies | Aaron Michael Ring, Jens-Peter Volkmer, Irving L. Weissman, Nan Guo Ring | 2020-09-22 |
| 10723803 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2020-07-28 |
| 10406179 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Irving L. Weissman, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr | 2019-09-10 |
| 10358472 | High affinity CD47 analogs | Chia Chi Ho, Kenan Christopher Garcia, Aaron Michael Ring, Irving L. Weissman, Nan Guo Ring | 2019-07-23 |
| 10316094 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Aaron Michael Ring, Irving L. Weissman | 2019-06-11 |
| 10184004 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2019-01-22 |
| 10081680 | Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies | Aaron Michael Ring, Jens-Peter Volkmer, Irving L. Weissman, Nan Guo Ring | 2018-09-25 |
| 10064925 | Use of anti-CD47 agents to enhance immunization | Diane Tseng, Jens-Peter Volkmer, Stephen Willingham, Irving L. Weissman | 2018-09-04 |
| 9945870 | Methods for determining responsiveness to an anti-CD47 agent | Irving L. Weissman | 2018-04-17 |
| 9944911 | High affinity Sirp-alpha reagents and methods of using | Aaron Michael Ring, Kenan Christopher Garcia, Aron Levin, Irving L. Weissman | 2018-04-17 |
| 9771428 | CD47 targeted therapies for the treatment of infectious disease | Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune, Irving L. Weissman | 2017-09-26 |